Swedbank’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZVRA
Swedbank's ZVRA Position: Q3 2026 in Review
Swedbank increased its Zevra Therapeutics (ZVRA) stake by 108% in Q3 2026, buying an estimated $5.63M and bringing the position to 914,532 shares worth $10M. The position accounts for 0.01% of the portfolio, ranked #504.
Swedbank first reported a position in ZVRA in Q2 2026 and has held it in 2 quarters since. 174 funds tracked by Wall St. Rank hold ZVRA as of Q3 2026.
- Swedbank held 914,532 shares of Zevra Therapeutics worth $10M as of Q3 2026.
- Swedbank bought 475,122 Zevra Therapeutics shares in Q3 2026, an estimated $5.63M.
- Zevra Therapeutics made up 0.01% of Swedbank's portfolio in Q3 2026, its #504 holding.
- Swedbank first reported a position in Zevra Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 174 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q3 2026.
Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.